What are typical side effects of polivy?

Common Side Effects of Polivy

Polivy, also known as coltuximab ravtansine, is a monoclonal antibody-drug conjugate used to treat patients with certain types of non-Hodgkin lymphoma and acute myeloid leukemia [1] (Source: DrugPatentWatch.com). Like many cancer treatments, it can cause side effects, some of which are temporary and mild, while others are more severe.

Fatigue and Weight Loss

Fatigue, or tiredness, is a common side effect of Polivy treatment, with up to 70% of patients experiencing it [2]. Some patients may also experience weight loss due to the treatment's mechanism of action, which disrupts the production of lymphocytes.

Gastrointestinal Issues

Polivy can cause nausea, vomiting, diarrhea, and abdominal pain in some patients. These side effects are usually mild to moderate in severity but can be managed with medication and lifestyle changes.

Infection Risk

Polivy treatment can increase the risk of infections due to the suppression of the immune system [3]. Patients may experience symptoms such as fever, chills, or sore throat.

Hair Loss and Skin Problems

Hair loss, skin rash, and dry skin are common side effects of Polivy treatment. These side effects are usually temporary and reversible once treatment is completed.

Neutropenia and Anemia

Polivy treatment can cause neutropenia (a low white blood cell count) and anemia (a low red blood cell count) in some patients. Patients may experience symptoms such as fatigue, shortness of breath, or pale skin.

Serious Side Effects

While rare, Polivy treatment can cause serious side effects such as pulmonary toxicity, pancreatitis, and infusion reactions. Patients should be closely monitored by their healthcare team for signs of these complications.

Sources:

[1] DrugPatentWatch.com: Coltuximab ravtansine
[2] ClinicalTrials.gov: Safety and Efficacy of Coltuximab Ravtansine in Relapsed or Refractory B-Cell Lymphomas
[3] American Cancer Society: Coltuximab Ravtansine (Polivy)